Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response

Published:2021-08-19 Issue: Volume: Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Rawding Piper A.¹²^ORCID,Bu Jiyoon¹²^ORCID,Wang Jianxin²^ORCID,Kim Da Won¹²^ORCID,Drelich Adam J.¹²^ORCID,Kim Youngsoo³^ORCID,Hong Seungpyo¹²³⁴^ORCID

Affiliation:

1. Pharmaceutical Sciences Division School of Pharmacy, University of Wisconsin‐Madison Madison Wisconsin USA

2. Wisconsin Center for NanoBioSystems University of Wisconsin‐Madison Madison Wisconsin USA

3. Department of Pharmacy Yonsei University Incheon Republic of Korea

4. Yonsei Frontier Lab Yonsei University Seoul Republic of Korea

Funder

Division of Materials Research

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1752

Reference177 articles.

1. Dendrimers: synthesis, applications, and properties

2. The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

3. Roles of PD‐1/PD‐L1 pathway: Signaling, cancer, and beyond;Ai L.;Advances in Experimental Medicine and Biology,2020

4. Trastuzumab targeted neratinib loaded poly‐amidoamine dendrimer nanocapsules for breast cancer therapy;Aleanizy F. S.;International Journal of Nanomedicine,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrimers—Novel Therapeutic Approaches for Alzheimer’s Disease;Biomedicines;2024-08-20

2. Programmed Death 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Gene Expression in Peripheral Blood Mononuclear Cells Can Serve as Prognostic Biomarkers for Hepatocellular Carcinoma;Cancers;2024-04-13

3. Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm;Heliyon;2024-04

4. Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies;Journal of Vascular and Interventional Radiology;2024-02

5. Simulation-based approaches for drug delivery systems: Navigating advancements, opportunities, and challenges;Journal of Molecular Liquids;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3